Flagler Hospital, Inc. Privacy, Confidentiality and HIPAA/PHI in Research Post-Test & Evaluation

Post-Test

Participant demographics:

Question Title

* 1. Full Name:

Question Title

* 2. Please indicate credentials

Physician-MD/DO

PA/ARNP

Other

Other (please specify)

Question Title

* 3. What type of certificate do you wish?

CE Broker reporting only; no certificate needed

Electronic

Paper

E-mail or physical address to send certificate

Question Title

* 4. Florida license number for CE Broker reporting:

Question Title

* 5. How many credit(s) are you claiming:

0.50

0.75

1.00 (maximum)

Other (please specify)

Flagler Hospital, Inc. Privacy, Confidentiality and HIPAA/PHI in Research Post-test (a passing score of 80% is required).

Question Title

* 6. Which of the following is not one of the three principles of the Belmont Report?

Beneficence

Justice

Autonomy

Respect for persons

Question Title

* 7. Which of the following is a key function of IRB members?

Evaluate confidentiality in research application by considering strategies of Principal Investigators to protect confidentiality of research data.

Dispose of research data sheets and paper records properly.

Determine specifically to whom research participants share their personal, private information

None of the above

Question Title

* 8. Which of the following describes the HIPAA Privacy Rule?

Refers to private information for which the identity of research participants is or may readily be ascertained by the Principal Investigator.

Establishes the conditions under which protected health information may be used or disclosed by covered entities for research purposes.

Refers to information that is no longer individually identifiable and cannot be used, alone or in combination with other reasonably available information, to identify the individual.

Refers to the release, transfer, provision of, access to, or divulging in any other manner of information outside the entity holding the information

Question Title

* 9. Which of the following best describes the research as defined in the Privacy Rule?

A term use to describe informal data collection that contributes to performance improvement.

A systematic investigation including testing and evaluation designed to contribute exclusively to risk management.

A systematic investigation, including research development, testing, and evaluation, designed to develop or contribute to generalizable knowledge.

All of the above.

Question Title

* 10. Protected health information authorization in research may be altered or waived by an IRB provided that the research could not practicably be conducted without alteration or waiver of authorization.

True

False

Question Title

* 11. Which of the following describes when a Data Use Agreement should be used?

When a Principal Investigator shares a research data set with his/her own research team.

When a Principal Investigator shares a data set with a colleague in quality management at another institutional exclusively for performance improvement.

When a Principal Investigator shares a limited research data set with a colleague at another institution or private registry not involved in the research.

When a Principal Investigator shares a research data set with the IRB at the research site.

Question Title

* 12. Limited Data Set information is not de-identified information and is still subject to requirements of the HIPAA Privacy Rule.

True

False

Question Title

* 13. Which of the following statements regarding protected health information in research is true:

Information about decedents who have been deceased for less than 50 years is NOT considered protected health information

Information about decedents who have been deceased for more that 50 years is NOT considered protected health information.

Information about decedents who have been deceased for more than 50 years IS considered protected health information.

Information about decedents is NEVER considered protected health information at any time during the research process.

Question Title

* 14. If an IRB approved protocol is not submitted after the Reviews Preparatory to Research process, the abstracted protected health information data must not be analyzed or disseminated in any form.

True

False

Question Title

* 15. Research participants may revoke in writing their protected health information research authorization at any time during the research process, EXCEPT to the extent that the Principal Investigator has collected and/or analyzed the participants' protected health information research data.

True

False

Question Title

* 16. According to the revised Common Rule, one of the basic elements of informed consent involves which of the following?

Explaining how identifiable private information or identifiable biospecimens are protected in research.

Explaining that research participants information or biospecimens collected as part of the research will automatically be used for future research studies.

Explaining how identifies are never removed from identifiable private information or identifiable biospecimens in research.

None of the above

Question Title

* 17. Questions that must be answered by Principal Investigators through informed consent process include which of the following?

What will happen with my protected health information and/or biospecimens used in this study? How will the researchers protect my information?

When does my permission to use my protected health information expire?

What protected health information about me could be seen by the researchers or by other people? Why? Who might see it?

What happens to information about me after the study is over or if I cancel my permission to use my personal health information?

All of the above.